KPV-10 5mg × 10 vials

A synthetic peptide studied for inflammatory response research, immune modulation pathways, skin-barrier models, gastrointestinal inflammation research, antimicrobial activity, melanocortin-related mechanisms, and broader tissue-protection protocols.

Product Overview

Compound: KPV-10 / KPV
Strength: 5 mg per vial
Injection type: Research protocol dependent
Frequency: Research protocol dependent

Reconstitution

Amount in vial: 5 mg
BAC water: 2 mL
Amount per unit: 25 mcg per unit

Research Dose

Protocol dependent.

Notes

KPV is a short peptide sequence derived from the C-terminal region of alpha-melanocyte-stimulating hormone. It has been studied for its role in inflammatory response modulation, immune-cell signaling, skin inflammation models, wound-healing pathways, and gastrointestinal barrier research.

Research literature has examined KPV in relation to cytokine modulation, antimicrobial activity, epithelial tissue protection, inflammatory bowel disease models, dermatitis-related pathways, and broader immune-regulation mechanisms.

KPV is often discussed in research contexts connected to melanocortin biology, but it should not be treated as a standard therapeutic product or consumer dosing protocol.

Most available evidence comes from laboratory, animal, and limited clinical-context research. No standard consumer dosing protocol should be assumed.

Use only within appropriate research or professional guidance frameworks.